Healthequity (HQY) EPS (Weighted Average and Diluted) (2013 - 2026)

Healthequity's EPS (Weighted Average and Diluted) history runs 14 years deep, the most recent figure standing at $0.82 for Q2 2026.

• In Q2 2026, EPS (Weighted Average and Diluted) rose 34.43% year-over-year to $0.82; the TTM figure through Apr 2026 stood at $2.67 (up 94.89% YoY), while the FY2026 annual figure was $2.46, up 125.69% from the prior year.
• EPS (Weighted Average and Diluted) was $0.82 for Q2 2026 at Healthequity, up from $0.58 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.82 in Q2 2026 to a low of -$0.39 in Q1 2022.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.24 across 5 years, with a median of $0.24 in 2023.
• The sharpest annual moves came in 2022 and 2024: EPS (Weighted Average and Diluted) sank 657.14% in 2022, then soared 12220.86% in 2024.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.02 in 2022, then surged by 950.0% to $0.17 in 2023, then sank by 64.71% to $0.06 in 2024, then jumped by 883.33% to $0.59 in 2025, then surged by 38.98% to $0.82 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.82 (Q2 2026), $0.58 (Q1 2026), and $0.59 (Q4 2025), per Business Quant data.